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 Supporting Information 
EXPERIMENTAL METHODS 
Mold and device fabrication. A 5-inch chrome mask drafted with the mold design (using 
AutoCAD software) and 4-inch silicon wafers were sent to a semiconductor processing foundry 
(Integrated Systems, Inc. ISSYS) for DRIE processing to create a silicon hard mold with 40 m 
thick features. The design consisted of a series of twenty 10-µm wide serpentine channels (with 
3 turns) spaced 30 µm apart. The hard mold was then placed in a chlorotrimethylsilane (TCMS) 
vapor chamber for 20 minutes. A PDMS mixture (10 parts Sylgard 184 A:1 part Sylgard 184 B 
curing agent) was poured onto the mold in a petri dish, degassed for 1 hour in a vacuum 
dessicator, and then baked at 80 oC until the samples were softly cured (~20 min). The PDMS 
mold replica was then cut out of the bulk PDMS and through-holes were punched at the locations 
of the channel inlets and outlets. The microfluidic mold replica was then rinsed with IPA and DI 
water, airgun dried, and dust was removed with scotch tape. The device was then centered on a 
clean polylysine-coated glass slide and bonded by baking for 4 hours at 80 oC. 
 
Validation of oligonucleotide set. The oligonucleotide sequences were chosen based on a pre-
validated set of 12 orthogonal 40-mer oligos, each containing a unique 20-mer sequence 
followed by a 20-mer poly-A tail as shown in Supplementary Table 1. These oligos had 
originally been screened for having very low calculated melting temperatures for hair-pin 
structures, self-hybridization, and cross-hybridization. Three of the sequences served as anchor 
sequences, with their complements serving as the “tail” portions of the bridging sequences. The 
other 9 sequences served as the “head” portions of the bridging sequences, with their 
complements serving as the conjugate strands for the cells. The 20-mer head and tail sequences 
 were appended to each other via a 20-mer polyA sequence, creating 60-bp bridging sequences as 
shown in Supplementary Table 2. For the anchor oligonucleotides, a length of 80 base pairs 
(two identical 40-mer sequences (appended end-to-end) was found to be optimal in ensuring 
sufficient contact area with the polylysine surface to anchor the cells. 
 
First flow-patterning step. Approximately 100 µM solutions of oligos A, B, and C (“anchor” 
sequences) were flowed into channels 1, 2, and 3 respectively. This was simultaneously repeated 
for each additional set of three channels. The solutions were flowed in at around 3 psi via 
external 23-gauge pin adapters connected to Tygon lines, which were hooked up to an external 
pressure source and pressure gauge. The solutions were flowed until 1 µL droplets formed at the 
outlets, indicating the channels were completely filled. The device was then stored in a dessicator 
at room temperature for 2 days to allow for complete evaporation of water, leaving behind the 
DNA stripes on the substrate. The PDMS was then peeled away and the patterned glass slide was 
baked at 80 oC for 2 – 4 hours to facilitate DNA bonding to the polylysine-coated slide. In the 
meantime, a second PDMS mold replica was fabricated and rinsed thoroughly with IPA and DI 
H2O, then airgun dried, and dust was again removed using scotch tape. Once removed from the 
oven, the slide was allowed to cool to room temperature and rinsed briefly with DI H2O to 
remove excess salts and unbound DNA, then dried with an airgun. The second PDMS mold 
replica was then placed on the patterned slide oriented 90o-clockwise with respect to the original 
position of the first PDMS mold replica in the first patterning step. The device was then baked at 
80 oC for 4 hours (for stronger bonding). 
 
 Second flow-patterning step. A 3 % BSA/PBS blocking buffer solution was then flowed into 
all device channels for one hour at 3 psi. For 3 x 3 Arrays: Solutions 1, 2, 3 (bridging sequences) 
were flowed into channels 1, 2, & 3, respectively, for one hour at 3 psi. This was simultaneously 
repeated for each additional set of three channels in the device. Solution 1: 50 µM each of oligo 
strands A’-i, B’-ii, C’-iii in 3 % BSA/PBS; solution 2: 50 µM each of oligo strands A’-iv, B’-v, 
and C’-vi in 3 % BSA/PBS; solution 3: 50 µM each of oligo strands A’-vii, B’-viii, and C’-ix in 
3 % BSA/PBS. For 3 x 1 Arrays:  Solution 1 was flowed into multiple adjacent channels. A 3 % 
BSA/PBS buffer solution was then flowed into each channel for 1 hour to remove excess 
unbound DNA. The PDMS was then peeled off, and the slide was incubated in a 3 % BSA/PBS 
bath (to block areas previously in contact with the PDMS), followed by rinsing with PBS, and 
airgun drying. 
 
DNA microarray validation. Once these DNAs were patterned into densely packed 3 x 3 grids 
or 3 x 1 grids, the patterned slide underwent a second cross-talk validation assay (now using just 
the 9 dye-conjugated complements i’ through ix’) to ensure that no new crosstalk had been 
introduced by having two orthogonal sequences tethered into a single bridging sequence. This 
assay also served to assess whether there was leakage between microfluidic patterning channels, 
which would manifest as smearing of the fluorescent signal between oligo spots in the grid. 
 
Conjugating cells with DNA. Prior to conjugation, media was decanted from the cell culture 
dishes and the dishes were rinsed 3 times with 1x PBS. Each dish was then incubated at room 
temperature for 10 minutes with 3 mL of a 40 µM solution of NHS-biotin in PBS (Solulink 
protocol). The culture dishes were then rinsed 3 times with media to remove excess unreacted 
 biotin. Next, 3 µL of 1 mg/mL SaC-oligo in 1 mL of 3 % BSA/PBS was added to each dish, 
followed by incubation at 37 oC for 5 minutes. The biotin-streptavidin binding reaction is 
complete in under 1 minute, but the reaction can proceed longer without causing harm to the 
cells. iii’-SaC was used to address α cells and neurons; ii’-SaC was used to address β cells and 
astrocytes. The culture dishes were then rinsed again with 3 % BSA/PBS 3 times to remove 
excess unbound SaC-oligo. Approximately 3 mL of warm (37 oC) trypsin was added to each 
culture dish and allowed to incubate for 3 minutes at 37 oC (to detach cells), followed by 5 mL 
trypsin-neutralizing solution and 5 mL of media. Each cell suspension was then centrifuged at 
~150 RCF for 5 min in a 15 mL falcon tube. The supernatant was aspirated, and oligo-
conjugated cells were resuspended at a concentration of 10 million cells / mL in 2 µM EDTA in 
3 % BSA/PBS.  
 
Cell culture. All cell cultures were incubated in a 37 oC humidity-controlled incubator with 5 % 
CO2/95 % air. Mouse cell-line derived pancreatic α cells (alpha TC1 clone 6, ATCC, Manassas, 
VA) were cultured in DMEM (Invitrogen Cat. No. 31600-034) containing: 10 % FBS (heat-
inactivated), 15mM HEPES, 0.1 mM non-essential amino acids, 0.02 % BSA, 1.5 g/L sodium 
bicarbonate, 3.0 g/L glucose. Mouse cell-line derived pancreatic β cells (Beta-TC-6, ATCC) 
were cultured in 15 % FBS/DMEM. Experiments were conducted a week after plating. Human 
Primary Neurons (ScienCell Research Labs, Carlsbad, CA) were cultured in Neuronal Medium 
(ScienCell), and used for experiments 2 days after plating. Human Primary Astrocytes 
(ScienCell) were cultured and continued to divide in Astrocyte Medium (ScienCell) and were 
used 4 days after plating. 
 
 Cell patterning. Two distinct experiments were carried out, one with neurons and astrocytes and 
one with α cells and β cells. In both cases, 200 µL of a single oligo-conjugated cell type (2 
million cells total) was pipetted onto a pre-blocked ultra-dense oligo-patterned slide, followed by 
incubation at 37 oC for 30 min. The cell-patterned slide was then swirled lightly in 3 % 
BSA/PBS to remove non-specifically bound cells. This procedure was then repeated on the same 
slide (either immediately or within a couple days) using the second oligo-conjugated cell type. A 
dye-conjugated DNA reference marker (50 nM i’-Cy3) was added prior to patterning of the cells 
to assess whether the cells were binding to the correct spots (relative to the reference marker). 
 
Hydrogel encapsulation of cells5. A 10 % solution of polyethylene glycol diacrylate (PEG-DA) 
(MW 3400) in DMEM was filtered through a filter membrane with 0.2 µm pores. Separately, 30 
mg of 2,2-Dimethoxy-2-phenylacetophenone (DMPA) photoinitiator was dissolved in 100 µL N-
vinylpyrrolidone. Then, 10 µL of DMPA solution was added to 1 mL of PEG-DA solution and 
vortexed. Approximately 150 µm-thick polished glass coverslips were then placed on the cell-
patterned polylysine slide on either side of the cell-patterned area. A third coverslip was 
positioned such that it bridged the first two, creating a channel in which the cell-patterned glass 
substrate served as the floor, and the 3 coverslips served as the walls and ceiling. The PEG pre-
polymer solution was then pipetted into this channel and cured for 5 minutes under a UV lamp at 
4 mW/cm2 to form a thin (150 µm) hydrogel layer encasing the cells. The hydrogel layer was 
then peeled off keeping the cell pattern within intact. By stacking and aligning multiple such 
layers on top of each other, a three-dimensional tissue-like structure was created. The tissue 
construct was then placed in a culture dish with media at 37 oC. 
 
 Islet cell function and viability assessment. Approximately 200 µL of a 5 µg/mL i’-anti-insulin 
Ab (R&D Systems, Minneapolis, MN) DNA-antibody conjugate in 15 % FBS/DMEM media 
solution was added to an islet cell patterned slide and allowed to hybridize to the spots of i DNA, 
followed by incubation at 37 oC for 2 days to allow insulin from nearby β cells to bind the 
conjugate.  The slide was then gently rinsed three times with media followed by addition of a 
200 µL solution of 2 µg/mL biotinylated insulin detection antibody (GeneTex, Irvine, CA) in 
media, which was allowed to incubate at 37 oC for 1 hour. Again, the slide was gently rinsed 
three times with media, followed by a 1 hour incubation at 37 oC of a 200 µL solution of 5 
µg/mL streptavidin-Cy5 conjugate (eBioscience, San Diego, CA) for fluorescence detection. A 
final triple rinse with media was performed. Cell viability was examined by labeling with calcein 
AM (5 M) and ethidium homodimer (2.5 M) (live/dead) fluorescent stains (Molecular 
Probes). 
 
Oligo orthogonality validation method. To validate that the designed oligo set was truly 
orthogonal, cross-talk assays were performed on the twelve oligos. First, the twelve primary 
strands were array-spotted on a polylysine-coated glass slide, baked at 80 oC for 2 – 4 hours, 
rinsed briefly with DI water, and airgun dried. A thin slab of PDMS with 12 pre-cut square holes 
was then bonded to the spotted glass slide, forming 12 assay wells. The wells were then blocked 
with 3% BSA/PBS for an hour. Twelve solutions, each containing 50 nM of a distinct dye-
conjugated complementary strand in 3 % BSA/PBS, were prepared and pipetted into the wells, 
such that each well was incubated with a different complementary strand for an hour. An 
additional complementary oligo (also at 50 nM) with a distinct dye color was added at this step 
as a reference marker. The same reference marker was used in all twelve wells. The wells were 
 then rinsed with 3 % BSA/PBS, the PDMS was peeled off, and the slide was rinsed with 1X PBS 
followed by DI water, then airgun dried. The slide was then scanned using a fluorescent 
microarray scanner to determine if more than one of the twelve spots fluoresced, suggesting 
cross-talk. If this occurred, the sequence assayed would be considered insufficiently orthogonal 
to the rest of the panel and would be replaced by a different sequence. 
Our lab has previously validated a set of 12 orthogonal oligos, whose sequences (not 
including the 20-mer polyA tail) are shown in Supplementary Table 1. The first 3 sequences 
(A, B, C) can serve as the anchor sequences, as follows:   
2X A-3’-polyA 
ATCCTGGAGCTAAGTCCGTAAAAAAAAAAAAAAAAAAAAAATCCTGGAGCTAAGTCCGTAAAAAAAAAAAAAAAAAAAAA 
2X B-3’-polyA 
GCCTCATTGAATCATGCCTAAAAAAAAAAAAAAAAAAAAAGCCTCATTGAATCATGCCTAAAAAAAAAAAAAAAAAAAAA 
2X C-3’-polyA 
GCACTCGTCTACTATCGCTAAAAAAAAAAAAAAAAAAAAAGCACTCGTCTACTATCGCTAAAAAAAAAAAAAAAAAAAAA 
 
 
 
 
 
 
 
 
 
 
 
 
 Supplementary Table 1.  List of 12 orthogonal DNA oligomers and their complementary 
sequences. 
 
 
Supplementary Table 2.  The complements to the anchors and the 9 remaining sequences which 
are coupled together to form bridging DNA sequences. 
A'-i TACGGACTTAGCTCCAGGATAAAAAAAAAAAAAAAAAAAAATGGTCGAGATGTCAGAGTA 
B'-ii TAGGCATGATTCAATGAGGCAAAAAAAAAAAAAAAAAAAAATGTGAAGTGGCAGTATCTA 
C'-iii TAGCGATAGTAGACGAGTGCAAAAAAAAAAAAAAAAAAAAATCAGGTAAGGTTCACGGTA
A'-iv TACGGACTTAGCTCCAGGATAAAAAAAAAAAAAAAAAAAAGAGTAGCCTTCCCGAGCATT 
B'-v TAGGCATGATTCAATGAGGCAAAAAAAAAAAAAAAAAAAAATTGACCAAACTGCGGTGCG
C'-vi TAGCGATAGTAGACGAGTGCAAAAAAAAAAAAAAAAAAAATGCCCTATTGTTGCGTCGGA
A'-vii TACGGACTTAGCTCCAGGATAAAAAAAAAAAAAAAAAAAATCTTCTAGTTGTCGAGCAGG 
B'-viii TAGGCATGATTCAATGAGGCAAAAAAAAAAAAAAAAAAAATAATCTAATTCTGGTCGCGG 
C'-ix TAGCGATAGTAGACGAGTGCAAAAAAAAAAAAAAAAAAAAGTGATTAAGTCTGCTTCGGC 
 
 
 
A    ATCCTGGAGCTAAGTCCGTA A' TACGGACTTAGCTCCAGGAT  
B    GCCTCATTGAATCATGCCTA B' TAGGCATGATTCAATGAGGC 
C  GCACTCGTCTACTATCGCTA C' TAGCGATAGTAGACGAGTGC  
i  ATGGTCGAGATGTCAGAGTA i' TACTCTGACATCTCGACCAT  
i i  ATGTGAAGTGGCAGTATCTA ii' TAGATACTGCCACTTCACAT  
i i i   ATCAGGTAAGGTTCACGGTA iii' TACCGTGAACCTTACCTGAT  
i v  GAGTAGCCTTCCCGAGCATT iv' AATGCTCGGGAAGGCTACTC 
v    ATTGACCAAACTGCGGTGCG v' CGCACCGCAGTTTGGTCAAT   
v i  TGCCCTATTGTTGCGTCGGA vi' TCCGACGCAACAATAGGGCA 
v i i   TCTTCTAGTTGTCGAGCAGG vii' CCTGCTCGACAACTAGAAGA   
v i ii   TAATCTAATTCTGGTCGCGG viii' CCGCGACCAGAATTAGATTA 
i x  GTGATTAAGTCTGCTTCGGC ix' GCCGAAGCAGACTTAATCAC   
  
  
 
Supplementary Figure 1.  Viability assay for 
astrocytes: a) upon assembly and b) after 2 days of 
incubation. These cells continued to divide and 
propagate throughout the slide area over this time 
period as their pattern was not fixed by a hydrogel film.*  
For the freshly assembled astrocytes, only 1 cell out of 
100 was found to be non-viable. After two days of 
incubation, all cells appeared viable, likely because the 
few dead cells had detached from the slide surface. Cell 
viability was examined by labeling with calcein AM (5 
M) and ethidium homodimer (2.5 M) (live/dead) 
fluorescent stains (Molecular Probes).  Live cells exhibit 
green fluorescence, while dead cells fluoresce red. 
 
 
 
 
 
 
 
*In our studies of encasing patterned cells in hydrogel films, cell division and mobility within the hydrogel matrix was 
not observed, likely due to the strong mechanical barrier provided by the rigid PEG membrane. The use of lower PEG 
concentrations or reduced UV light power would likely decrease this mechanical barrier, but at the expense of the 
rigidity needed to maintain the pattern integrity. 
 
